Amgen Inc.
AMGNUpdated . Prices are snapshots and may be delayed.
Amgen Inc. price chart
AI Outlook for Amgen Inc.
Bullish postureAmgen is in a bullish technical posture, though short-term momentum is negative. The stock trades about 4.7% below its 52-week high and sits 48% above its 52-week low. The long-term trend is +15.8% versus the 200-day average, and the recent 24-hour change is +2.0%.
- Long-term trend+17.8% vs 200-day average
- Medium-term trend+4.7% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Updated 4d ago. Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Amgen Inc. performance
About Amgen Inc.
Amgen Inc. is a biotechnology company based in the United States, listed on NASDAQ since 1983 (ticker AMGN).
The shares trade at a price-to-earnings ratio of 25.2. The dividend yield is 3.21%.
Amgen Inc. market data
What is the price of Amgen Inc. today?
Amgen Inc. (AMGN) is at $434.03, −0.41% on the day.
What is the 52-week range of Amgen Inc.?
Over the past year Amgen Inc. has traded between $288.00 and $447.03. It is currently 92% of the way up that range.
What is the P/E ratio of Amgen Inc.?
Amgen Inc. trades at a price-to-earnings ratio of 25.2.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.